With Competition Closing In, Novo Details Oral Semaglutide Weight Loss At ADA

Lilly’s Oral GLP-1 Also Impressed

 
• By Mandy Jackson
  
Measuring tape on a wood background
Novo's oral semaglutide measures up well with Wegovy in obesity • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D